Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Mechanism difference Semaglutide (GLP-1 agonist): appetite regulation, satiety, improved glycemic control (New England Journal of Medicine) Tirzepatide (GLP-1/GIP agonist): broader incretin effects, robust appetite/weight effects (New England Journal of Medicine) AOD-9604: targeted fat-metabolism signaling
This can lead to a decrease in calorie intake and, ultimately, weight loss
Without the right expertise, companies often end up with brittle integrations, unreliable infrastructure, and compliance gaps that become costly to fix later
The company posted a profit of $126 million in 2024 compared to a net loss of $25 million a year ago
US$ 20.36
US$ 26.15
US$ 26.81
US$ 27.30
US$ 21.69
US$ 21.23
US$ 23.81
US$ 23.76
